Approval · Notice of Compliance 2166 · 2001
AERIUS: Notice of Compliance 2166
Issued May 29, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2166
- Date
- May 29, 2001
- Company
- Schering Canada Inc.
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Histamine h1 receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AERIUS | 02243919 | Marketed |
Medicinal ingredients
- DESLORATADINE 5 MG per TAB